Reuters logo
BRIEF-Versartis enters commercial supply agreement with Boehringer Ingelheim Biopharmaceuticals
December 28, 2016 / 9:50 PM / 9 months ago

BRIEF-Versartis enters commercial supply agreement with Boehringer Ingelheim Biopharmaceuticals

Dec 28 (Reuters) - Versartis Inc

* Versartis - Initial term of agreement continues for period of 8 years, after initial term, agreement will automatically renew for periods of 3 years each

* Says on Dec 21, co entered into a commercial supply agreement with Boehringer Ingelheim Biopharmaceuticals GMBH

* Versartis Inc says pursuant to agreement co engaged Boehringer as a contract manufacturer to manufacture bulk drug substance for co's somavaratan (VRS-317) Source text: (bit.ly/2i8Skfr) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below